Emil D. Kakkis

2012

In 2012, Emil D. Kakkis earned a total compensation of $401.4K as President and Chief Executive Officer at Ultragenyx Pharmaceutical.

Compensation breakdown

Non-Equity Incentive Plan$92,125
Salary$300,172
Other$9,056
Total$401,353

Kakkis received $300.2K in salary, accounting for 75% of the total pay in 2012.

Kakkis also received $92.1K in non-equity incentive plan and $9.1K in other compensation.

Rankings

In 2012, Emil D. Kakkis' compensation ranked 9,388th out of 11,487 executives tracked by ExecPay. In other words, Kakkis earned more than 18.3% of executives.

ClassificationRankingPercentile
All
9,388
out of 11,487
18th
Division
Manufacturing
3,467
out of 4,253
19th
Major group
Chemicals And Allied Products
957
out of 1,203
20th
Industry group
Drugs
718
out of 925
22nd
Industry
Pharmaceutical Preparations
552
out of 700
21st
Source: SEC filing on May 23, 2014.

Kakkis' colleagues

We found two more compensation records of executives who worked with Emil D. Kakkis at Ultragenyx Pharmaceutical in 2012.

2012

Thomas Kassberg

Ultragenyx Pharmaceutical

Chief Business Officer and Senior Vice President

2012

Shalini Sharp

Ultragenyx Pharmaceutical

Chief Financial Officer

News

You may also like